The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Irvine, K. R.
Right arrow Articles by Restifo, N. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Irvine, K. R.
Right arrow Articles by Restifo, N. P.

The Journal of Immunology, Vol 156, Issue 1 238-245, Copyright © 1996 by American Association of Immunologists

ARTICLES

Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases

KR Irvine, JB Rao, SA Rosenberg and NP Restifo
Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

DNA immunization can result in the induction of Ag-specific cellular and humoral immune responses and in protective immunity in several Ag systems. To evaluate the utility of DNA-based immunization as a potential cancer treatment strategy, we employed an experimental murine tumor, CT26, expressing the model tumor-associated Ag, beta- galactosidase (beta-gal), designated CT26.CL25. A plasmid expressing beta-gal (pCMV/beta-gal) administered by particle-mediated gene delivery to the epidermis using a hand-held, helium-driven "gene gun" induced beta-gal-specific Ab and lytic responses. Immunization with this construct prevented the growth of pulmonary metastatic tumor, and the adoptive transfer of splenocytes generated by pCMV/beta-gal in vivo immunization and cultured in vitro with the beta-gal876-884 immunodominant peptide reduced the number of established pulmonary nodules. DNA immunization alone had little or no impact on the growth of established lung metastases. To enhance the function of DNA immunization for active immunotherapy, a panel of cytokines was added as adjuvants following DNA administration. Significant reduction in the number of established metastases was observed when human rIL-2, mouse rIL-6, human rIL-7, or mouse rIL-12 were given after DNA inoculation; mouse rIL-12 as an adjuvant had the most profound effect. These findings suggest that the cytokines involved in the activation and expansion of lymphocyte populations may improve the therapeutic effects of DNA immunization. Given the ease with which plasmid DNA can be prepared to high purity for safe use in humans with infectious diseases and cancers, DNA immunization administered together with cytokine adjuvant may be an attractive alternative to recombinant viral vaccines.


This article has been cited by other articles:


Home page
 BloodHome page
M. Rafei, J. H. Wu, B. Annabi, L. Lejeune, M. Francois, and J. Galipeau
A GMCSF and IL-15 fusokine leads to paradoxical immunosuppression in vivo via asymmetrical JAK/STAT signaling through the IL-15 receptor complex
Blood, March 1, 2007; 109(5): 2234 - 2242.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
W. W. Overwijk, K. E. de Visser, F. H. Tirion, L. A. de Jong, T. W. H. Pols, Y. U. van der Velden, J. G. van den Boorn, A. M. Keller, W. A. Buurman, M. R. Theoret, et al.
Immunological and Antitumor Effects of IL-23 as a Cancer Vaccine Adjuvant
J. Immunol., May 1, 2006; 176(9): 5213 - 5222.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. Sehouli, A. Mustea, D. Koensgen, and W. Lichtenegger
Interleukin-1 Receptor Antagonist Gene Polymorphism in Epithelial Ovarian Cancer
Cancer Epidemiol. Biomarkers Prev., November 1, 2003; 12(11): 1205 - 1208.
[Abstract] [Full Text]

Home page
 Ann OncolHome page
J. Sehouli, A. Mustea, D. Koensgen, F. C.-K. Chen, and W. Lichtenegger
Interleukin-1 receptor antagonist gene polymorphism is associated with increased risk of epithelial ovarian cancer
Ann. Onc., October 1, 2003; 14(10): 1501 - 1504.
[Abstract] [Full Text] [PDF]

Home page
 Crit. Rev. Oral Biol. Med.Home page
K. Devaraj, M. L. Gillison, and T.-C. Wu
DEVELOPMENT OF HPV VACCINES FOR HPV-ASSOCIATED HEAD AND NECK SQUAMOUS CELL CARCINOMA
Crit. Rev. Oral. Biol. Med., September 1, 2003; 14(5): 345 - 362.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. M. Segal, D. D. Glass, and E. M. Shevach
Cutting Edge: IL-10-Producing CD4+ T Cells Mediate Tumor Rejection
J. Immunol., January 1, 2002; 168(1): 1 - 4.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W. S. Meng, L. H. Butterfield, A. Ribas, V. B. Dissette, J. B. Heller, G. A. Miranda, J. A. Glaspy, W. H. McBride, and J. S. Economou
{alpha}-Fetoprotein-specific Tumor Immunity Induced by Plasmid Prime-Adenovirus Boost Genetic Vaccination
Cancer Res., December 1, 2001; 61(24): 8782 - 8786.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. E. Touloukian, W. W. Leitner, P. F. Robbins, S. A. Rosenberg, and N. P. Restifo
Mining the Melanosome for Tumor Vaccine Targets: P.polypeptide Is a Novel Tumor-associated Antigen
Cancer Res., November 1, 2001; 61(22): 8100 - 8104.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. Garcia-Navarro, B. Blanco-Urgoiti, P. Berraondo, R. Sanchez de la Rosa, A. Vales, S. Hervas-Stubbs, J. J. Lasarte, F. Borras, J. Ruiz, and J. Prieto
Protection against Woodchuck Hepatitis Virus (WHV) Infection by Gene Gun Coimmunization with WHV Core and Interleukin-12
J. Virol., October 1, 2001; 75(19): 9068 - 9076.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
P. Lee, F. Wang, J. Kuniyoshi, V. Rubio, T. Stuges, S. Groshen, C. Gee, R. Lau, G. Jeffery, K. Margolin, et al.
Effects of Interleukin-12 on the Immune Response to a Multipeptide Vaccine for Resected Metastatic Melanoma
J. Clin. Oncol., September 15, 2001; 19(18): 3836 - 3847.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
J. D. Ahlers, I. M. Belyakov, S. Matsui, and J. A. Berzofsky
Mechanisms of cytokine synergy essential for vaccine protection against viral challenge
Int. Immunol., July 1, 2001; 13(7): 897 - 908.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. von Mehren, P. Arlen, J. Gulley, A. Rogatko, H. S. Cooper, N. J. Meropol, R. K. Alpaugh, M. Davey, S. McLaughlin, M. T. Beard, et al.
The Influence of Granulocyte Macrophage Colony-Stimulating Factor and Prior Chemotherapy on the Immunological Response to a Vaccine (ALVAC-CEA B7.1) in Patients with Metastatic Carcinoma
Clin. Cancer Res., May 1, 2001; 7(5): 1181 - 1191.
[Abstract] [Full Text]

Home page
 J. Leukoc. Biol.Home page
D. J. Shedlock and D. B. Weiner
DNA vaccination: antigen presentation and the induction of immunity
J. Leukoc. Biol., December 1, 2000; 68(6): 793 - 806.
[Abstract] [Full Text]

Home page
 J. Virol.Home page
S. A. Leachman, R. E. Tigelaar, M. Shlyankevich, M. D. Slade, M. Irwin, E. Chang, T. C. Wu, W. Xiao, S. Pazhani, D. Zelterman, et al.
Granulocyte-Macrophage Colony-Stimulating Factor Priming plus Papillomavirus E6 DNA Vaccination: Effects on Papilloma Formation and Regression in the Cottontail Rabbit Papillomavirus-Rabbit Model
J. Virol., September 15, 2000; 74(18): 8700 - 8708.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
W. W. Leitner, H. Ying, D. A. Driver, T. W. Dubensky, and N. P. Restifo
Enhancement of Tumor-specific Immune Response with Plasmid DNA Replicon Vectors
Cancer Res., January 1, 2000; 60(1): 51 - 55.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
V. Bronte, E. Apolloni, R. Ronca, P. Zamboni, W. W. Overwijk, D. R. Surman, N. P. Restifo, and P. Zanovello
Genetic Vaccination with "Self" Tyrosinase-related Protein 2 Causes Melanoma Eradication but not Vitiligo
Cancer Res., January 1, 2000; 60(2): 253 - 258.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
C. P. Simmons, P. Mastroeni, R. Fowler, M. Ghaem-maghami, N. Lycke, M. Pizza, R. Rappuoli, and G. Dougan
MHC Class I-Restricted Cytotoxic Lymphocyte Responses Induced by Enterotoxin-Based Mucosal Adjuvants
J. Immunol., December 15, 1999; 163(12): 6502 - 6510.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
C. Jiang, D. M. Magee, and R. A. Cox
Coadministration of Interleukin 12 Expression Vector with Antigen 2 cDNA Enhances Induction of Protective Immunity against Coccidioides immitis
Infect. Immun., November 1, 1999; 67(11): 5848 - 5853.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. A. Rosenberg, J. C. Yang, D. J. Schwartzentruber, P. Hwu, F. M. Marincola, S. L. Topalian, N. P. Restifo, M. Sznol, S. L. Schwarz, P. J. Spiess, et al.
Impact of Cytokine Administration on the Generation of Antitumor Reactivity in Patients with Metastatic Melanoma Receiving a Peptide Vaccine
J. Immunol., August 1, 1999; 163(3): 1690 - 1695.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. A. Cornell, H. G. A. Bouwer, D. J. Hinrichs, and R. A. Barry
Genetic Immunization of Mice Against Listeria monocytogenes Using Plasmid DNA Encoding Listeriolysin O
J. Immunol., July 1, 1999; 163(1): 322 - 329.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. D. Syrengelas and R. Levy
DNA Vaccination Against the Idiotype of a Murine B Cell Lymphoma: Mechanism of Tumor Protection
J. Immunol., April 15, 1999; 162(8): 4790 - 4795.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
W. W. Overwijk, D. S. Lee, D. R. Surman, K. R. Irvine, C. E. Touloukian, C.-C. Chan, M. W. Carroll, B. Moss, S. A. Rosenberg, and N. P. Restifo
Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: Requirement for CD4+ T lymphocytes
PNAS, March 16, 1999; 96(6): 2982 - 2987.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
Adam. D. Cohen, J. D. Boyer, and D. B. Weiner
Modulating the immune response to genetic immunization
FASEB J, December 1, 1998; 12(15): 1611 - 1626.
[Abstract] [Full Text]

Home page
 Infect. Immun.Home page
B. Wizel, N. Garg, and R. L. Tarleton
Vaccination with Trypomastigote Surface Antigen 1-Encoding Plasmid DNA Confers Protection against Lethal Trypanosoma cruzi Infection
Infect. Immun., November 1, 1998; 66(11): 5073 - 5081.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Gurunathan, K. R. Irvine, C.-Y. Wu, J. I. Cohen, E. Thomas, C. Prussin, N. P. Restifo, and R. A. Seder
CD40 Ligand/Trimer DNA Enhances Both Humoral and Cellular Immune Responses and Induces Protective Immunity to Infectious and Tumor Challenge
J. Immunol., November 1, 1998; 161(9): 4563 - 4571.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. Paglia, E. Medina, I. Arioli, C. A. Guzman, and M. P. Colombo
Gene Transfer in Dendritic Cells, Induced by Oral DNA Vaccination With Salmonella typhimurium, Results in Protective Immunity Against a Murine Fibrosarcoma
Blood, November 1, 1998; 92(9): 3172 - 3176.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Youssef, G. Wildbaum, G. Maor, N. Lanir, A. Gour-Lavie, N. Grabie, and N. Karin
Long-Lasting Protective Immunity to Experimental Autoimmune Encephalomyelitis Following Vaccination with Naked DNA Encoding C-C Chemokines
J. Immunol., October 15, 1998; 161(8): 3870 - 3879.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
A. Porgador, K. R. Irvine, A. Iwasaki, B. H. Barber, N. P. Restifo, and R. N. Germain
Predominant Role for Directly Transfected Dendritic Cells in Antigen Presentation to CD8+ T Cells after Gene Gun Immunization
J. Exp. Med., September 21, 1998; 188(6): 1075 - 1082.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
W. W. Overwijk, A. Tsung, K. R. Irvine, M. R. Parkhurst, T. J. Goletz, K. Tsung, M. W. Carroll, C. Liu, B. Moss, S. A. Rosenberg, et al.
gp100/pmel 17 Is a Murine Tumor Rejection Antigen: Induction of "Self"-reactive, Tumoricidal T Cells Using High-affinity, Altered Peptide Ligand
J. Exp. Med., July 20, 1998; 188(2): 277 - 286.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. M. Celluzzi and L. D. Falo Jr.
Cutting Edge: Physical Interaction Between Dendritic Cells and Tumor Cells Results in an Immunogen That Induces Protective and Therapeutic Tumor Rejection
J. Immunol., April 1, 1998; 160(7): 3081 - 3085.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. H. Horspool, P. J. Perrin, J. B. Woodcock, J. H. Cox, C. L. King, C. H. June, D. M. Harlan, D. C. St. Louis, and K. P. Lee
Nucleic Acid Vaccine-Induced Immune Responses Require CD28 Costimulation and Are Regulated by CTLA4
J. Immunol., March 15, 1998; 160(6): 2706 - 2714.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. I. Cardoso, N. Sixt, A. Vallier, J. Fayolle, R. Buckland, and T. F. Wild
Measles Virus DNA Vaccination: Antibody Isotype Is Determined by the Method of Immunization and by the Nature of both the Antigen and the Coimmunized Antigen
J. Virol., March 1, 1998; 72(3): 2516 - 2518.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. D. Macklin, D. McCabe, M. W. McGregor, V. Neumann, T. Meyer, R. Callan, V. S. Hinshaw, and W. F. Swain
Immunization of Pigs with a Particle-Mediated DNA Vaccine to Influenza A Virus Protects against Challenge with Homologous Virus
J. Virol., February 1, 1998; 72(2): 1491 - 1496.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. Andre, B. Seed, J. Eberle, W. Schraut, A. Bultmann, and J. Haas
Increased Immune Response Elicited by DNA Vaccination with a Synthetic gp120 Sequence with Optimized Codon Usage
J. Virol., February 1, 1998; 72(2): 1497 - 1503.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Tuting, C. C. Wilson, D. M. Martin, Y. L. Kasamon, J. Rowles, D. I. Ma, C. L. Slingluff Jr., S. N. Wagner, P. van der Bruggen, J. Baar, et al.
Autologous Human Monocyte-Derived Dendritic Cells Genetically Modified to Express Melanoma Antigens Elicit Primary Cytotoxic T Cell Responses In Vitro: Enhancement by Cotransfection of Genes Encoding the Th1-Biasing Cytokines IL-12 and IFN-{alpha}
J. Immunol., February 1, 1998; 160(3): 1139 - 1147.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y.-H. Chow, B.-L. Chiang, Y.-L. Lee, W.-K. Chi, W.-C. Lin, Y.-T. Chen, and M.-H. Tao
Development of Th1 and Th2 Populations and the Nature of Immune Responses to Hepatitis B Virus DNA Vaccines Can Be Modulated by Codelivery of Various Cytokine Genes
J. Immunol., February 1, 1998; 160(3): 1320 - 1329.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. B. Caspar, S. Levy, and R. Levy
Idiotype Vaccines for Non-Hodgkin's Lymphoma Induce Polyclonal Immune Responses That Cover Mutated Tumor Idiotypes: Comparison of Different Vaccine Formulations
Blood, November 1, 1997; 90(9): 3699 - 3706.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
J. M. Specht, G. Wang, M. T. Do, J. S. Lam, R. E. Royal, M. E. Reeves, S. A. Rosenberg, and P. Hwu
Dendritic Cells Retrovirally Transduced with a Model Antigen Gene Are Therapeutically Effective against Established Pulmonary Metastases
J. Exp. Med., October 20, 1997; 186(8): 1213 - 1221.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
V. Bronte, M. W. Carroll, T. J. Goletz, M. Wang, W. W. Overwijk, F. Marincola, S. A. Rosenberg, B. Moss, and N. P. Restifo
Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine
PNAS, April 1, 1997; 94(7): 3183 - 3188.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.